p3 primary cell solution + supplement 1 (Lonza)
Lonza is a verified supplier 
Lonza manufactures this product 
90
Structured Review
Lonza
p3 primary cell solution + supplement 1
P3 Primary Cell Solution + Supplement 1, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p3+primary+cell+solution+++supplement+1/supplement+1/bio_rxiv__2025__06__06__658308-146-15-22
Average 90 stars, based on 1 article reviews
P3 Primary Cell Solution + Supplement 1, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p3+primary+cell+solution+++supplement+1/supplement+1/bio_rxiv__2025__06__06__658308-146-15-22
Average 90 stars, based on 1 article reviews
p3 primary cell solution + supplement 1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Transfection:Article Title: TDP-43 safeguards the embryo genome from L1 retrotransposition Article Snippet: mESCs were trypsinized and washed with 1× PBS (Nacalai Tesque) once. .. Cells (2 × 10 5 ) were transfected with 40 pmol of siRNA and 20 μl of the Article Title: TDP-43 safeguards the embryo genome from L1 retrotransposition. Article Snippet: Single-cell clones were picked and expanded after 7 days. siRNA transfection mESCs were trypsinized and washed with 1× PBS (Nacalai Tesque) once. .. Cells (2 × 105) were transfected with 40 pmol of siRNA and 20 l of the Article Title: THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling. Article Snippet: RESEARCH ARTICLE | APRIL 15 2024 THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling El ra Amalia Deborah; ... et. al J Immunol (2024) 212 (11): 1819–1828. https://doi.org/10.4049/jimmunol.2300771 Related Content Themis2 Is Not Required for B Cell Development, Activation, and Antibody Responses J Immunol (July,2014) Interchangeability of Themis1 and Themis2 in Thymocyte Development Reveals Two Related Proteins with Conserved Molecular Function J Immunol (August,2012) D ow nloaded from http://journals.aai.org/jim m unol/article-pdf/212/11/1819/1657457/ji2300771.pdf by guest on 12 M ay 2025 THEMIS2 Impairs Antitumor Activity of NK Cells by other:Article Title: Imaging CRISPR-Edited CAR-T Cell Therapies with Optical and Positron Emission Tomography Reporters Article Snippet: 1 x 10 6 activated T cells were pelleted and resuspended in 20 μL of Article Title: The BTLA-HVEM axis restricts CAR T cell efficacy in cancer. Article Snippet: Puneeth Guruprasad, Alberto Carturan, Yunlin Zhang, Jong Hyun Cho, Kingsley Gideon Kumashie , Ruchi P. Patel , Ki-Hyun Kim, Jong-Seo Lee, Yoon Lee, Jong Hoon Kim, Junho Chung, Akshita Joshi, Ivan Cohen, Maksim Shestov, Guido Ghilardi, Jaryse Harris, Raymone Pajarillo, Mathew Angelos, Yong Gu Lee, Shan Liu, Jesse Rodriguez, Michael Wang, Hatcher J. Ballard, Aasha Gupta, Ositadimma H. Ugwuanyi, Seok Jae Albert Hong, Audrey C. Bochi-Layec, Christopher T. Sauter, Linhui Chen, Luca Paruzzo , Shane Kammerman, Olga Shestova, Dongfang Liu , Laura A. Vella, Stephen J. Schuster, Jakub Svoboda, Patrizia Porazzi & Marco Ruella Article Title: Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes Article Snippet: PiZZ1-ZZ iPSCs were treated for 3 h with 10 mm Y-27632 (Tocris, catalog #1254), then dissociated to a single-cell suspension using Gentle Cell reagent (StemCell Technologies). iPSCs (1 106) were resuspended in Article Title: The Thienopyrimidinone Gamhépathiopine Targets the Q O Site of Plasmodium falciparum Cytochrome b . Article Snippet: The plasmids were resuspended in 10 μL of TE buffer, and before transfection, 100 μL CRISPR:Article Title: THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling. Article Snippet: RESEARCH ARTICLE | APRIL 15 2024 THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling El ra Amalia Deborah; ... et. al J Immunol (2024) 212 (11): 1819–1828. https://doi.org/10.4049/jimmunol.2300771 Related Content Themis2 Is Not Required for B Cell Development, Activation, and Antibody Responses J Immunol (July,2014) Interchangeability of Themis1 and Themis2 in Thymocyte Development Reveals Two Related Proteins with Conserved Molecular Function J Immunol (August,2012) D ow nloaded from http://journals.aai.org/jim m unol/article-pdf/212/11/1819/1657457/ji2300771.pdf by guest on 12 M ay 2025 THEMIS2 Impairs Antitumor Activity of NK Cells by |